×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EPRX – eupraxia pharmaceuticals inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EPRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/15
08:02 am
eprx
Eupraxia Pharmaceuticals (NASDAQ:EPRX) had its price target raised by analysts at Cantor Fitzgerald from $11.00 to $19.00. They now have an "overweight" rating on the stock.
Low
Report
Eupraxia Pharmaceuticals (NASDAQ:EPRX) had its price target raised by analysts at Cantor Fitzgerald from $11.00 to $19.00. They now have an "overweight" rating on the stock.
1/9
08:02 am
eprx
Eupraxia Pharmaceuticals (NASDAQ:EPRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Neutral
Report
Eupraxia Pharmaceuticals (NASDAQ:EPRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
1/8
07:05 pm
eprx
Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy [Yahoo! Finance]
Medium
Report
Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy [Yahoo! Finance]
1/8
09:53 am
eprx
Eupraxia Pharmaceuticals Up 1.8% As Reports "Positive" Findings From Resolve Trial [Yahoo! Finance]
High
Report
Eupraxia Pharmaceuticals Up 1.8% As Reports "Positive" Findings From Resolve Trial [Yahoo! Finance]
1/8
07:34 am
eprx
Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy
High
Report
Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy
12/12
05:52 am
eprx
Eupraxia Pharmaceuticals (NASDAQ:EPRX) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
Medium
Report
Eupraxia Pharmaceuticals (NASDAQ:EPRX) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
12/4
10:20 pm
eprx
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here's Why [Yahoo! Finance]
Medium
Report
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here's Why [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
1/8
12:02 pm
eprx
Form 6-K EUPRAXIA PHARMACEUTICALS For: Jan 08
Medium
Report
Form 6-K EUPRAXIA PHARMACEUTICALS For: Jan 08
11/14
04:45 pm
eprx
Form SCHEDULE 13G/A EUPRAXIA PHARMACEUTICALS Filed by: DISBROW ROBERT
Low
Report
Form SCHEDULE 13G/A EUPRAXIA PHARMACEUTICALS Filed by: DISBROW ROBERT
11/14
09:11 am
eprx
Form SCHEDULE 13G EUPRAXIA PHARMACEUTICALS Filed by: Beutel, Goodman & Co Ltd.
Low
Report
Form SCHEDULE 13G EUPRAXIA PHARMACEUTICALS Filed by: Beutel, Goodman & Co Ltd.
11/13
12:15 pm
eprx
Form SCHEDULE 13G EUPRAXIA PHARMACEUTICALS Filed by: MANCHESTER MANAGEMENT CO LLC
Low
Report
Form SCHEDULE 13G EUPRAXIA PHARMACEUTICALS Filed by: MANCHESTER MANAGEMENT CO LLC
11/4
04:01 pm
eprx
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 04
Medium
Report
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 04
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: